Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Align Technology Inc., 3 years.
Align Technology Inc.
Director
Neurocrine Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 17, 2024 | Align Technology Inc. | Option exercise | +1,029 | — | — |
| May 17, 2024 | Neurocrine Biosciences Inc. | Option exercise | +4,199 | — | — |
| Mar 14, 2024 | Neurocrine Biosciences Inc. | Option exercise | +20,000 | $39.79 | $795,800 |
| Mar 14, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −20,000 | $139.42 | $2,788,400 |
| Mar 14, 2024 | Neurocrine Biosciences Inc. | Option exercise | +20,000 | $39.79 | $795,800 |
| Mar 14, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −20,000 | $139.41 | $2,788,200 |
| May 30, 2023 | Align Technology Inc. | Gift | −10,000 | — | — |
| May 17, 2023 | Align Technology Inc. | Option exercise | +1,114 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.